AI-powered vision diagnostics company Heru (Miami, Florida) has announced it has surpassed one million eyes tested on its wearable platform — a milestone that the company says reflects its rapid adoption across US eye care practices.
Developed at Bascom Palmer Eye Institute, Heru’s platform replaces multiple legacy devices with a portable, FDA-registered wearable that automates and digitizes several traditional eye exams. The system uses artificial intelligence to deliver objective, standardized results and improved efficiency in clinical practice.
Mohamed Abou Shousha, founder and CEO of the company, and associate professor of clinical ophthalmology at the University of Miami Miller School of Medicine, commented: “This milestone… represents a million opportunities where patients received a higher standard of care, where doctors were empowered with immediate, objective data, and where vision-threatening conditions may have been detected earlier”
Heru’s success is underpinned by more than a decade of research and clinical validation at Bascom Palmer, where the technology was conceived. The platform’s origins in a major academic research center have lent it strong clinical credibility and helped accelerate adoption by both enterprise eye care providers and private practices nationwide.
“At Bascom Palmer, our goal is to constantly advance the paradigm of care for patients everywhere,” said Eduardo C. Alfonso, Director of the Bascom Palmer Eye Institute, and Professor and Chair of Ophthalmology at the University of Miami Miller School of Medicine. “Heru is a direct result of this commitment, transforming a decade of dedicated research in artificial intelligence and virtual reality into a practical tool that is now elevating clinical care on a national scale. Surpassing one million eyes tested demonstrates that the future we envisioned, one that is more efficient, accessible, and data-driven, is now a reality.”
